🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in strengthening compliance measures.

Digital Trading Operations

Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at residence.

After minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts display black plastic packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially significant medical dangers”.